Vancouver, Canada (ots/PRNewswire) - Burcon NutraScience
Corporation (TSX-V: BU) announced today that its Puratein(R) and
Supertein(TM) canola protein isolates are GRAS (Generally Recognized
As Safe) for their intended use in a variety of food and beverage
applications. The products have been self-affirmed GRAS through an
independent evaluation by a panel of qualified experts in the fields
of food safety, toxicology, nutritional sciences, food allergies and
pediatric nutrition. Burcon's Puratein(R) and Supertein(TM) are the
first canola protein isolates to have attained GRAS status in the
United States. GRAS status permits Puratein(R) and Supertein(TM) to
be marketed and used in a variety of mainstream foods and beverages
for human consumption.
Puratein(R) and Supertein(TM) are expected to participate with
soy, dairy and egg proteins in the multi-billion dollar global
protein ingredient market. Protein ingredients are valued for both
their nutritional qualities as well as their functional applications
in foods and beverages.
Puratein(R) is a canola protein isolate with functional
properties that include emulsification, gel formation, thickening,
formation of heat-stable foams, and water- and ingredient-binding.
Applications for Puratein(R) include dressings, meat substitutes,
baked goods and protein bars, among many others.
Supertein(TM) is a canola protein isolate with functional
properties including excellent solubility, the ability to form
transparent solutions and foaming. Applications for Supertein(TM)
include beverages, confectionery, aerated desserts, and protein bars,
among many others. Nutritionally, the proteins are equally exciting
with unique amino acid profiles.
"Achieving GRAS status is a major advancement in the
commercialization of Puratein(R) and Supertein(TM), the world's first
food-grade canola proteins," stated Johann F. Tergesen, Burcon's
President & COO who added, "We benefited from the expertise of our
development partner, Archer Daniels Midland Company, throughout this
process. Our combined team is focused on creating a competitive
advantage for food and beverage manufacturers with these exciting new
GRAS status is the standard set by the US Food and Drug
Administration for food ingredients to be accepted for use in foods
and beverages. "GRAS" is an acronym for the phrase: "generally
recognized as safe". With today's announcement, Burcon's Puratein(R)
and Supertein(TM) are self-affirmed GRAS. Burcon and ADM have chosen
to also pursue GRAS notification for Puratein(R) and Supertein(TM).
GRAS notification is a voluntary procedure whereby a company informs
the FDA of its determination that the use of a substance is GRAS. A
substance is GRAS Notified when, after reviewing the GRAS
notification, the FDA responds with a no-objection letter if it is
satisfied with the submission. It is important to note however that
Burcon's Puratein(R) and Supertein(TM) canola proteins are considered
GRAS from today's date for the intended applications.
For more information about Burcon view our new website at
About Burcon NutraScience
Burcon is a research and development company developing a
portfolio of composition, application, and process patents around its
plant protein extraction and purification technology. The goal of
Burcon's research is to develop its patented process to utilize
inexpensive oilseed meals for the production of purified plant
proteins that exhibit valuable nutritional, functional or
nutraceutical profiles. Burcon, in conjunction with Archer Daniels
Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM).
Canola, recognized for its nutritional qualities, is the
second-largest oilseed crop in the world after soybeans. Burcon's
goal is to develop Puratein(R) and Supertein(TM) to participate with
soy, dairy, and egg proteins in the expanding multi-billion-dollar
protein ingredient market, with potential uses in prepared foods,
nutritional supplements, and personal care products.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President & Chief Operating Officer
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements that involve risks and uncertainties. These
forward-looking statements relate to, among other things, plans and
timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in
this press release that are not historical fact. Our expectations
regarding the prospect for future success depend upon our ability to
develop and sell products, which we do not produce today and cannot
be sold without further research and development. When used in this
press release, the words "goal," "intend," "believes" and "potential"
and similar expressions, generally identify forward-looking
statements. These statements reflect our current expectations. They
are subject to a number of risks and uncertainties. In light of the
many risks and uncertainties surrounding the development of a source
of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this
press release will be realized.
For further information: Jade Cheng, Chief Financial Officer,
Burcon NutraScience Corporation, +1-604-733-0896/(888)408-7960
toll-free, email@example.com, http://www.burcon.ca; AXINO AG: Sven
Olsson, Investor Relations Europe, Konigstrasse 26, 70173 Stuttgart,
Germany, Tel. +49-711-25-35-92-30 / Fax +49-711-25-35-92-33,
ots Originaltext: Burcon NutraScience Corporation
Im Internet recherchierbar: http://www.presseportal.ch
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896/(888)408-7960 toll-free,
firstname.lastname@example.org, AXINO AG: Sven Olsson, Investor
Relations Europe, Konigstrasse 26, 70173 Stuttgart, Germany, Tel.
+49-711-25-35-92-30 / Fax +49-711-25-35-92-33, email@example.com